Register for the event here or join the conference call through the Events section of the SAB BIO Company website. A live question and answer session will follow the formal presentations. A replay of ...
MIAMI, Jan. 23, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback